VIYASH — Viyash Scientific Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Viyash Scientific, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	PRESS	PRESS
Standards:	—	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,128	14,209	13,697	30,068	34,203
Cost of Revenue
Gross Profit	6,198	5,148	5,579	15,367	18,576
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	13,550	15,022	13,640	29,431	30,439
Operating Profit	579	-813	57.2	637	3,764
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	529	-1,377	-546	132	3,490
Provision for Income Taxes
Net Income After Taxes	448	-1,220	-296	158	2,247
Minority Interest
Net Income Before Extraordinary Items
Net Income	410	-1,212	-359	232	1,773
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	410	-1,212	-359	232	1,773
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.65	-3.2	-1.13	1.74	4.65
Dividends per Share